Analyst/Investor Day July 15, 2026 9:00 AM EDTCompany ParticipantsJan-Hendrik Mohr - Chairman of Management Board & ...
A new AAV-based gene therapy successfully improved seizures, behavior, and brain activity in fragile X syndrome mice, paving the way for clinical development.
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果